Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects - PubMed (original) (raw)

Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

P Hainaut et al. Nucleic Acids Res. 1997.

Abstract

In recent years, there has been an exponential increase in the number of p53 mutations identified in human cancers. The p53 mutation database consists of a list of point mutations in thep53 gene of human tumors and cell lines, compiled from the published literature and made available through electronic media. The database is now maintained at the International Agency for Research on Cancer (IARC) and is updated twice a year. The current version contains records on 5091 published mutations and is expected to surpass the 6000 mark in the January 1997 release. The database is available in various formats through the European Bioinformatics Institute (EBI) ftp server at: ftp://ftp.ebi.ac.uk/pub/databases/p53/ or by request from IARC (p53database@iarc.fr) and will be searchable through the SRS system in the near future. This report provides a description of the criteria for inclusion of data and of the current formats, a summary of the relevance ofp53 mutation analysis to clinical and biological questions, and a brief discussion of the prospects for future developments.

PubMed Disclaimer

Similar articles

• IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools.
  Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC, Montesano R. Hainaut P, et al. Nucleic Acids Res. 1998 Jan 1;26(1):205-13. doi: 10.1093/nar/26.1.205. Nucleic Acids Res. 1998. PMID: 9399837 Free PMC article.
• Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation.
  Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, Harris CC. Hollstein M, et al. Nucleic Acids Res. 1996 Jan 1;24(1):141-6. doi: 10.1093/nar/24.1.141. Nucleic Acids Res. 1996. PMID: 8594564 Free PMC article.
• IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.
  Hernandez-Boussard T, Rodriguez-Tome P, Montesano R, Hainaut P. Hernandez-Boussard T, et al. Hum Mutat. 1999;14(1):1-8. doi: 10.1002/(SICI)1098-1004(1999)14:1<1::AID-HUMU1>3.0.CO;2-H. Hum Mutat. 1999. PMID: 10447253 Review.
• Database of p53 gene somatic mutations in human tumors and cell lines.
  Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sørlie T, Hovig E, Smith-Sørensen B, Montesano R, Harris CC. Hollstein M, et al. Nucleic Acids Res. 1994 Sep;22(17):3551-5. Nucleic Acids Res. 1994. PMID: 7937055 Free PMC article.
• New approaches to understanding p53 gene tumor mutation spectra.
  Hollstein M, Hergenhahn M, Yang Q, Bartsch H, Wang ZQ, Hainaut P. Hollstein M, et al. Mutat Res. 1999 Dec 17;431(2):199-209. doi: 10.1016/s0027-5107(99)00162-1. Mutat Res. 1999. PMID: 10635987 Review.

Cited by

• MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma.
  Lohkamp LN, Schinz M, Gehlhaar C, Guse K, Thomale UW, Vajkoczy P, Heppner FL, Koch A. Lohkamp LN, et al. PLoS One. 2016 Jun 2;11(6):e0156422. doi: 10.1371/journal.pone.0156422. eCollection 2016. PLoS One. 2016. PMID: 27253461 Free PMC article.
• Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus.
  Kaneko K, Katagiri A, Konishi K, Kurahashi T, Ito H, Kumekawa Y, Yamamoto T, Muramoto T, Kubota Y, Nozawa H, Makino R, Kushima M, Imawari M. Kaneko K, et al. Br J Cancer. 2007 Feb 12;96(3):492-8. doi: 10.1038/sj.bjc.6603582. Br J Cancer. 2007. PMID: 17285122 Free PMC article.
• Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis--a pilot study.
  Moodley D, Mody GM, Chuturgoon AA. Moodley D, et al. Clin Rheumatol. 2010 Oct;29(10):1099-105. doi: 10.1007/s10067-010-1505-4. Epub 2010 Jun 10. Clin Rheumatol. 2010. PMID: 20532936
• Independent molecular development of metachronous glioblastomas with extended intervening recurrence-free interval.
  Martinez R, Schackert HK, von Kannen S, Lichter P, Joos S, Schackert G. Martinez R, et al. Brain Pathol. 2003 Oct;13(4):598-607. doi: 10.1111/j.1750-3639.2003.tb00488.x. Brain Pathol. 2003. PMID: 14655763 Free PMC article.
• Mismatch-induced DNA unbending upon duplex opening.
  Yuan C, Rhoades E, Heuer DM, Archer LA. Yuan C, et al. Biophys J. 2005 Oct;89(4):2564-73. doi: 10.1529/biophysj.105.065722. Epub 2005 Aug 5. Biophys J. 2005. PMID: 16085769 Free PMC article.

References

1. 1. J Natl Cancer Inst. 1992 Feb 19;84(4):246-52 - PubMed
2. 1. Mol Med Today. 1996 Jan;2(1):32-7 - PubMed
3. 1. Comput Appl Biosci. 1993 Feb;9(1):49-57 - PubMed
4. 1. Mutagenesis. 1993 Jul;8(4):275-83 - PubMed
5. 1. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8586-90 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal